Conversion to Combined Mycophenolate Mofetil and Low-Dose Calcineurin Inhibitor Therapy for Renal Dysfunction in Liver Transplant Patients: Never Too Late?

被引：0
|
作者：
Susanne Beckebaum
Vito R. Cicinnati
机构：
[1] University Hospital Essen,Department of Gastroenterology and Hepatology
[2] University of Duisburg-Essen,Department of General, Visceral and Transplantation Surgery
[3] University Hospital Essen,undefined
[4] University of Duisburg-Essen,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 6
页数：2
相关论文
共 50 条
  • [31] A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
    Zheng, Xiang
    Zhang, Weijie
    Zhou, Hua
    Cao, Ronghua
    Shou, Zhangfei
    Zhang, Shuwei
    Cheng, Ying
    Chen, Xuchun
    Ding, Chenguang
    Tang, Zuofu
    Li, Ning
    Shi, Shaohua
    Zhou, Qiang
    Chen, Qiuyuan
    Chen, Gang
    Chen, Zheng
    Zhou, Peijun
    Hu, Xiaopeng
    Zhang, Xiaodong
    Na, Ning
    Wang, Wei
    CHINESE MEDICAL JOURNAL, 2022, 135 (13) : 1597 - 1603
  • [32] Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil
    Sola, E
    Alférez, MJ
    Cabello, M
    Burgos, D
    Molina, MG
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1689 - 1690
  • [33] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [34] Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction
    Koch, RO
    Graziadei, IW
    Schulz, F
    Nachbaur, K
    Königsrainer, A
    Margreiter, R
    Vogel, W
    TRANSPLANT INTERNATIONAL, 2004, 17 (09) : 518 - 524
  • [35] Mycophenolate mofetil in pediatric liver transplant patients with renal dysfunction: Preliminary data
    Nobili, V
    PEDIATRIC TRANSPLANTATION, 2003, 7 (06) : 454 - 457
  • [36] Efficacy and safety of everolimus plus low-dose calcineurin inhibitor vs. mycophenolate mofetil plus standard-dose calcineurin inhibitor in renal transplant recipients: A systematic review and meta-analysis
    He, Lihong
    Deng, Jin
    Yang, Bo
    Jiang, Wei
    CLINICAL NEPHROLOGY, 2018, 89 (05) : 336 - 344
  • [37] Renal dysfunction in orthotopic liver transplant patients: A single center experience with calcineurine inhibitor dose reduction and introduction of mycophenolate mofetil.
    Mejzlik, V
    Studenik, P
    Kuman, M
    Ondrasek, J
    Cerny, J
    LIVER TRANSPLANTATION, 2005, 11 (07) : C42 - C42
  • [38] Replacement of calcineurin inhibitors by mycophenolate mofetil in liver transplanted patients with renal dysfunction -: Results in 37 patients
    Schlitt, HJ
    Barkmann, A
    Böker, KHW
    Schmidt, HHJ
    Rosenau, J
    Emmanouilidis, N
    Bahr, M
    Radermacher, J
    Manns, MP
    Klempnauer, J
    Nashan, B
    TRANSPLANTATION, 2000, 69 (08) : S168 - S168
  • [39] Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: Single-center experience
    Garcia, CE
    Ribeiro, HBG
    Garcia, RL
    Copstein, JLM
    Padilla, JM
    Santos, TE
    Amaral, DD
    Silva, AO
    D'Albucluerque, LAC
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1131 - 1132
  • [40] Conversion to combined therapy with sirolimus and mycophenolate mofetil improved renal function in stable renal transplant recipients
    Tsai, Meng-Kun
    Lee, Chih-Yuan
    Hu, Rey-Heng
    Lee, Po-Huang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2007, 106 (05) : 372 - 379
12345